Preface |
|
xv | |
|
Chapter 1 Introduction to Diet, Nutrition and Cancer |
|
|
1 | (12) |
|
|
|
Section 1 Dietary Components and Patterns |
|
|
|
Chapter 2 Bioactive Compounds from Fruits and Vegetables and Cancer Prevention |
|
|
13 | (1) |
|
|
|
|
|
|
13 | (1) |
|
2.2 Diet, Nutrition and Cancer |
|
|
14 | (1) |
|
|
15 | (7) |
|
|
15 | (1) |
|
2.3.2 Extra-nutritional Components that Increase Cancer Risk |
|
|
15 | (1) |
|
2.3.3 Extra-nutritional Components that Decrease Cancer Risk: BFCs |
|
|
16 | (6) |
|
|
22 | (5) |
|
Chapter 3 Vitamin D in Obesity and Cancer Prevention |
|
|
27 | (1) |
|
|
|
|
3.1 Background on Nutritional/Physiological Roles of Vitamin D |
|
|
27 | (2) |
|
3.2 Brief Historical Aspects on the Association of Vitamin D in Obesity and Cancer |
|
|
29 | (2) |
|
3.2.1 Vitamin D and Obesity |
|
|
29 | (1) |
|
3.2.2 Vitamin D and Cancer |
|
|
29 | (2) |
|
3.3 Cancer Preventive Actions of Vitamin D: Evidence from Epidemiological and Intervention Studies |
|
|
31 | (2) |
|
3.4 Impact of VDR Polymorphisms on Cancer Risk |
|
|
33 | (3) |
|
3.5 Potential Cellular and Molecular Mechanisms of Vitamin D |
|
|
36 | (4) |
|
3.5.1 Inhibition of Cell Proliferation |
|
|
36 | (1) |
|
|
37 | (1) |
|
3.5.3 Cell Differentiation |
|
|
38 | (1) |
|
3.5.4 Interaction of the Vitamin D System with Epigenetic Processes |
|
|
38 | (2) |
|
|
40 | (10) |
|
Chapter 4 Selenium and Cancer Prevention |
|
|
50 | (1) |
|
|
|
|
|
50 | (1) |
|
|
51 | (3) |
|
4.2.1 Metabolism, Synthesis and Functions of Selenoproteins |
|
|
51 | (2) |
|
4.2.2 Nutritional Recommendations |
|
|
53 | (1) |
|
|
53 | (1) |
|
4.2.4 Biomarkers of Se Status |
|
|
53 | (1) |
|
4.3 Epidemiological Evidence Linking Se and Cancer Prevention |
|
|
54 | (5) |
|
4.4 Challenges in Interpreting Findings from Clinical Trials: The Role of Genetics |
|
|
59 | (8) |
|
|
59 | (4) |
|
|
63 | (3) |
|
|
66 | (1) |
|
4.5 Proposed Mechanisms of Action by Se |
|
|
67 | (3) |
|
4.6 Perspectives: Epigenetics |
|
|
70 | (1) |
|
|
70 | (6) |
|
Chapter 5 Zinc and Cancer Prevention |
|
|
76 | (1) |
|
|
|
|
|
|
5.1 Zinc Intake: Recommendations, Deficiency, and Supplementation |
|
|
76 | (2) |
|
5.2 Main Biological Roles of Zinc |
|
|
78 | (3) |
|
|
78 | (2) |
|
|
80 | (1) |
|
|
80 | (1) |
|
5.3 The Roles of Zinc in Mammary Carcinogenesis |
|
|
81 | (4) |
|
|
82 | (1) |
|
5.3.2 Experimental Findings |
|
|
82 | (3) |
|
5.4 The Roles of Zn in Upper Digestive Tract Carcinogenesis |
|
|
85 | (3) |
|
|
85 | (1) |
|
5.4.2 Experimental Findings |
|
|
86 | (2) |
|
5.5 The Roles of Zinc in Hepatocarcinogenesis |
|
|
88 | (3) |
|
|
89 | (1) |
|
5.5.2 Experimental Findings |
|
|
89 | (2) |
|
5.6 Conclusion and Future Perspectives |
|
|
91 | (6) |
|
|
91 | (6) |
|
Chapter 6 Red and Processed Meat Consumption and Cancer Risk |
|
|
97 | (1) |
|
|
|
|
|
97 | (1) |
|
6.2 Epidemiological Studies |
|
|
98 | (2) |
|
6.3 Mechanisms of Association between Meat Consumption and Carcinogenesis |
|
|
100 | (1) |
|
6.3.1 Heme Iron, Oxidative Stress and Carcinogenesis |
|
|
100 | (1) |
|
6.3.2 Heme Iron, N-Nitroso Compounds (NOCs) and Carcinogenesis |
|
|
101 | (1) |
|
6.3.3 Heterocyclic Amines (HCAs), Polycyclic Aromatic Hydrocarbons (PAHs) and Carcinogenesis |
|
|
102 | (1) |
|
6.3.4 Saturated Fat and Carcinogenesis |
|
|
103 | (1) |
|
|
104 | (4) |
|
Chapter 7 Alcohol Intake and Cancer Risk |
|
|
108 | (1) |
|
|
|
|
|
108 | (2) |
|
7.2 Alcohol and Oroesophageal Cancers |
|
|
110 | (3) |
|
7.3 Alcohol and Colorectal Cancer |
|
|
113 | (3) |
|
7.4 Alcohol and Hepatobiliary Cancers |
|
|
116 | (2) |
|
7.5 Alcohol and Pancreatic Cancer |
|
|
118 | (1) |
|
7.6 Alcohol and Gastric Cancer |
|
|
119 | (1) |
|
|
119 | (9) |
|
|
120 | (8) |
|
Chapter 8 Fatty Acids and Cancer Risk |
|
|
128 | (1) |
|
|
|
|
128 | (1) |
|
8.2 Cancer Lipid Metabolism |
|
|
129 | (1) |
|
8.2.1 De Novo FA Synthesis |
|
|
130 | (2) |
|
8.2.2 Deregulation of FASN in Cancer Cells |
|
|
132 | (1) |
|
8.2.3 Is Deregulation of FASN an Early Event of Carcinogenesis? |
|
|
133 | (1) |
|
|
134 | (1) |
|
8.2.5 Lipid Peroxidation and Eicosanoid Synthesis |
|
|
135 | (1) |
|
8.2.6 Lipid Rafts in Cancer Cells |
|
|
136 | (1) |
|
8.2.7 Whole-body Lipid Metabolism and Cancer |
|
|
137 | (2) |
|
|
139 | (8) |
|
Chapter 9 Obesity and Cancer Risk |
|
|
147 | (1) |
|
|
|
|
|
147 | (2) |
|
9.2 Mechanisms Linking Obesity and Cancer |
|
|
149 | (1) |
|
9.2.1 Excessive Adipose Tissue |
|
|
149 | (1) |
|
9.2.2 Obesity-related Metabolism and Cancer |
|
|
150 | (3) |
|
|
153 | (1) |
|
9.3 Obesity and Cancer Prevention |
|
|
154 | (1) |
|
|
154 | (6) |
|
|
155 | (5) |
|
Chapter 10 Dietary Patterns and Cancer Risk |
|
|
160 | (1) |
|
|
|
160 | (1) |
|
|
161 | (1) |
|
10.3 A Priori Dietary Patterns and Cancer Risk |
|
|
162 | (2) |
|
10.4 A Posteriori Dietary Patterns and Cancer Risk |
|
|
164 | (1) |
|
|
165 | (6) |
|
Section 2 Cellular and Molecular Mechanisms |
|
|
|
Chapter 11 Nutritional Genomics and Cancer Prevention |
|
|
171 | (1) |
|
|
|
|
|
|
|
171 | (2) |
|
11.2 Nutrigenomics Perspectives on Polyphenols and Cancer Prevention |
|
|
173 | (1) |
|
11.3 Metabolomics Perspectives on Polyphenols and Cancer Prevention |
|
|
173 | (1) |
|
11.3.1 The Food Polyphenols Metabolome |
|
|
174 | (1) |
|
11.3.2 Metabolomics Platforms To Analyze Polyphenol Intake and Effects |
|
|
175 | (1) |
|
11.3.3 Bioavailability of Dietary Polyphenols |
|
|
175 | (2) |
|
11.3.4 Biomarkers of Polyphenol Intake |
|
|
177 | (1) |
|
11.3.5 Biomarkers of Polyphenol Biological Effects |
|
|
177 | (1) |
|
11.3.6 Integration of Metabolomics with Other Omics in a Systems Biology Perspective for Comprehensive Polyphenolic Compound Health Effects Elucidation |
|
|
178 | (1) |
|
|
179 | (4) |
|
|
179 | (4) |
|
Chapter 12 Nutrition, Epigenetics and Cancer Prevention |
|
|
183 | (1) |
|
|
|
|
|
183 | (1) |
|
12.2 Epigenetic Mechanisms in Normal Cells |
|
|
184 | (1) |
|
12.3 Epigenetics and Cancer |
|
|
185 | (1) |
|
12.4 Effects of Nutrients and BFCs on Epigenetic Mechanisms and Cancer Prevention |
|
|
185 | (1) |
|
12.4.1 Direct Effects of Nutrients and BFCs on Epigenetic Mechanisms and Cancer Prevention |
|
|
186 | (5) |
|
12.4.2 Indirect Effects of Nutrients on Epigenetic Mechanisms and Cancer Prevention |
|
|
191 | (3) |
|
12.5 Final Remarks Disclaimer |
|
|
194 | (13) |
|
Chapter 13 Maternal and Paternal Nutrition and Developmental Origins of Breast Cancer |
|
|
207 | (1) |
|
|
|
|
|
|
|
|
13.1 Developmental Origins of Breast Cancer |
|
|
207 | (2) |
|
13.2 Mothers' Exposure during Gestation and Lactation and Breast Cancer Risk in Daughters |
|
|
209 | (1) |
|
13.2.1 Epidemiological Evidence |
|
|
209 | (1) |
|
13.2.2 Experimental Evidence |
|
|
210 | (10) |
|
13.2.3 Epigenetic Deregulation and Maternal Breast Cancer Programming |
|
|
220 | (1) |
|
13.2.4 Mammary Stem Cells and Maternal Breast Cancer Programming |
|
|
221 | (1) |
|
13.3 Fathers' Exposures during Preconception and Breast Cancer Risk in Daughters |
|
|
222 | (2) |
|
13.3.1 Ancestral Paternal Environmental Exposures and Breast Cancer Development in Daughters |
|
|
222 | (1) |
|
13.3.2 Environmentally Induced Transmission of Breast Cancer Risk through the Male Germline: Possible Mechanisms |
|
|
223 | (1) |
|
|
224 | (6) |
|
|
225 | (5) |
|
Chapter 14 Eating Habits and Their Impact on Aging and Cancer |
|
|
230 | (1) |
|
|
|
|
14.1 Introduction: In Search of the Best Diet |
|
|
230 | (1) |
|
14.2 Caloric Restriction (CR) |
|
|
231 | (1) |
|
14.2.1 CR in Non-human Primates |
|
|
232 | (1) |
|
|
233 | (1) |
|
14.2.3 Anti-cancer Effects of CR |
|
|
234 | (1) |
|
14.2.4 Mechanisms of Action of CR |
|
|
235 | (7) |
|
|
242 | (2) |
|
14.3 Time-restricted Feeding (TRF) |
|
|
244 | (4) |
|
14.3.1 Feeding and the Circadian Clock |
|
|
246 | (2) |
|
14.4 Biological Mechanisms Linking Aging and Cancer |
|
|
248 | (4) |
|
14.4.1 Time-dependent Accumulation of Mutagenic Events |
|
|
248 | (1) |
|
14.4.2 Decline of Immune Surveillance |
|
|
249 | (1) |
|
|
250 | (1) |
|
14.4.4 The Age-associated, Neoplastic-prone Tissue Landscape |
|
|
250 | (2) |
|
14.5 Caloric Restriction Delays the Onset of the Age-associated, Neoplastic-prone Tissue Landscape |
|
|
252 | (1) |
|
|
252 | (9) |
|
Chapter 15 Nutrition, the Gastrointestinal Microbiota and Cancer Prevention |
|
|
261 | (1) |
|
|
|
|
15.1 The Microbiota and the Human Body |
|
|
261 | (1) |
|
15.1.1 The Gut Microbiota and the Immune System |
|
|
262 | (2) |
|
15.2 Gastrointestinal Microbiota and Carcinogenesis |
|
|
264 | (3) |
|
15.2.1 The Relationship between Oral and Esophageal Microbiota and Cancer |
|
|
264 | (1) |
|
15.2.2 Gastric Microbiota and Cancer |
|
|
265 | (1) |
|
15.2.3 Duodenum, Jejunum and Ileum Microbiota and Cancer Tissue Biopsies |
|
|
265 | (1) |
|
15.2.4 Colorectal Microbiota and Cancer |
|
|
266 | (1) |
|
|
267 | (1) |
|
15.3 Metabolic Components of Intestinal Microbiota and Carcinogenesis |
|
|
267 | (5) |
|
15.3.1 The Role of Bacterial Metabolism in CRC |
|
|
267 | (5) |
|
15.4 Biological Transformations of Diet-related Components and Cancer |
|
|
272 | (5) |
|
15.4.1 Food Fibers: The Short-chain Fatty Acids Case |
|
|
272 | (1) |
|
15.4.2 Food Lipids: The Secondary Bile Acids Case |
|
|
273 | (2) |
|
15.4.3 Protein Fermentation: Hydrogen Sulfide, Phenols, Ammonia, Polyamines and N-Nitroso compounds (NOCs) |
|
|
275 | (1) |
|
15.4.4 Trimethylamine N-Oxide (TMAO) |
|
|
276 | (1) |
|
|
277 | (17) |
|
Chapter 16 Nutrition, (Cancer-)Stem Cells and Cancer Prevention |
|
|
294 | (1) |
|
|
|
|
|
|
294 | (1) |
|
|
295 | (1) |
|
16.2.1 The Hierarchical Model of Tumor Evolution |
|
|
295 | (1) |
|
16.2.2 Cellular Origin and Identification of Cancer Stem Cells |
|
|
296 | (2) |
|
16.2.3 Regulation and Maintenance of Cancer Stem Cells |
|
|
298 | (1) |
|
16.3 Nutritional Impact on Cancer Stem Cell Signaling-Pathways |
|
|
299 | (8) |
|
16.3.1 Wnt Signaling Pathway |
|
|
301 | (2) |
|
16.3.2 Hedgehog Signaling Pathway |
|
|
303 | (1) |
|
16.3.3 Notch Signaling Pathway |
|
|
304 | (1) |
|
16.3.4 Other Targets for Bioactive Compounds in CSC Signaling and Biology |
|
|
305 | (2) |
|
16.4 Limitations and Perspectives |
|
|
307 | (12) |
|
|
310 | (9) |
|
|
|
Chapter 17 Nutrition and Colorectal Cancer Prevention |
|
|
319 | (1) |
|
|
|
319 | (1) |
|
17.2 The Cellular Origins of Colorectal Cancer |
|
|
320 | (1) |
|
17.3 Carbohydrates and Dietary Fibre |
|
|
321 | (1) |
|
17.3.1 Total Carbohydrate Intake |
|
|
321 | (1) |
|
17.3.2 The Absorption and Metabolism of Carbohydrate |
|
|
322 | (1) |
|
17.3.3 Dietary Fibre Intake |
|
|
323 | (1) |
|
17.3.4 Wholegrain Cereals |
|
|
324 | (1) |
|
17.4 Fruits and Vegetables |
|
|
325 | (2) |
|
17.4.1 Brassica Vegetables and Isothiocyanates |
|
|
326 | (1) |
|
17.5 Dietary Fat, Meat and Meat Products |
|
|
327 | (3) |
|
17.5.1 Fats and Fatty Acids |
|
|
327 | (2) |
|
17.5.2 Meat and Meat Products |
|
|
329 | (1) |
|
17.5.3 Does Vegetarianism Protect against CRC? |
|
|
329 | (1) |
|
17.6 Overweight, Obesity and Metabolic Status |
|
|
330 | (1) |
|
17.7 The Vulnerable Mucosa, Nutrition, and the Challenge for Future Research |
|
|
331 | (8) |
|
Chapter 18 Nutrition and Liver Cancer Prevention |
|
|
339 | (1) |
|
|
|
|
|
339 | (1) |
|
18.2 Hepatocarcinogenesis: Genetics |
|
|
340 | (1) |
|
18.3 Hepatocarcinogenesis: Epigenetics |
|
|
341 | (1) |
|
18.4 Diet and Liver Cancer |
|
|
341 | (1) |
|
18.4.1 Co-3 Polyunsaturated Fatty Acids (PUFAs) |
|
|
342 | (1) |
|
|
342 | (1) |
|
18.4.3 Diets Based on Whole Grains, Fruits and Vegetables |
|
|
342 | (1) |
|
18.5 Prevention of Liver Cancer: The Role of Chemoprevention |
|
|
343 | (8) |
|
18.5.1 Synthetic Compounds |
|
|
343 | (1) |
|
|
344 | (7) |
|
18.6 Final Considerations |
|
|
351 | (17) |
|
Chapter 19 Nutrition and Breast Cancer Prevention |
|
|
368 | (1) |
|
|
|
|
368 | (2) |
|
|
370 | (3) |
|
19.2.1 Dietary Fats and Breast Cancer Outcome |
|
|
372 | (1) |
|
19.3 Fruits and Vegetables |
|
|
373 | (1) |
|
19.3.1 Fruits and Vegetables and Breast Cancer Outcome |
|
|
374 | (1) |
|
|
374 | (2) |
|
19.4.1 Carotenoids and Breast Cancer Outcome |
|
|
375 | (1) |
|
|
376 | (2) |
|
19.5.1 Soy Foods and Breast Cancer Outcome |
|
|
377 | (1) |
|
19.6 Calcium and Vitamin D |
|
|
378 | (2) |
|
19.6.1 VitD and Breast Cancer Outcome |
|
|
378 | (2) |
|
|
380 | (12) |
|
Chapter 20 Nutrition and Prostate Cancer Prevention |
|
|
392 | (1) |
|
|
|
|
|
|
20.1 General Aspects of Prostate Cancer (PCa) |
|
|
392 | (2) |
|
|
393 | (1) |
|
|
393 | (1) |
|
|
394 | (1) |
|
20.2 Dietary Compounds that Increase PCa Risk |
|
|
394 | (2) |
|
20.2.1 High Energy Intake |
|
|
395 | (1) |
|
20.2.2 Heterocyclic Aromatic Amines |
|
|
395 | (1) |
|
|
395 | (1) |
|
20.2.4 High Carbohydrate Intake |
|
|
396 | (1) |
|
|
396 | (1) |
|
20.3 Dietary Compounds that Reduce PCa Risk |
|
|
396 | (2) |
|
|
397 | (1) |
|
|
397 | (1) |
|
|
398 | (1) |
|
20.3.4 Cruciferous Vegetables |
|
|
398 | (1) |
|
|
398 | (1) |
|
|
398 | (1) |
|
20.4 Environmental Chemical Contaminants and PCa Risk |
|
|
398 | (1) |
|
|
399 | (1) |
|
20.4.2 Polychlorinated Biphenyls (PCBs) |
|
|
399 | (1) |
|
20.5 Lifestyle and PCa Risk |
|
|
399 | (4) |
|
|
400 | (1) |
|
20.5.2 Diabetes Mellitus (DM) |
|
|
400 | (2) |
|
|
402 | (1) |
|
20.6 Nutrition and Epigenetic Markers |
|
|
403 | (1) |
|
20.7 Fetal Origins of PCa |
|
|
403 | (1) |
|
20.8 Concluding Remarks and Future Perspectives |
|
|
404 | (9) |
|
|
404 | (9) |
Subject Index |
|
413 | |